- Report
- January 2024
- 160 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- May 2021
- 120 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- August 2023
- 145 Pages
Global
From €2808EUR$3,150USD£2,428GBP
- Report
- May 2025
- 120 Pages
Global
From €4234EUR$4,750USD£3,662GBP
- Report
- July 2024
- 200 Pages
Global
From €4411EUR$4,949USD£3,815GBP
- Report
- July 2023
- 444 Pages
Global
From €3209EUR$3,600USD£2,775GBP
- Report
- July 2023
- 186 Pages
Middle East, Africa
From €1337EUR$1,500USD£1,156GBP
- Report
- September 2022
- 240 Pages
Global
From €4947EUR$5,550USD£4,278GBP
- Report
- January 2024
- 91 Pages
Global
From €3500EUR$4,206USD£3,133GBP
- Report
- April 2023
- 109 Pages
Global
From €3500EUR$4,206USD£3,133GBP

The Electroporator market is a subset of the biotechnology industry that focuses on the development and sale of electroporation devices. Electroporation is a process used to introduce foreign material into cells, such as DNA, by applying a brief electric pulse. This process is used in a variety of biotechnological applications, such as gene therapy, gene editing, and vaccine production. Electroporators are used to generate the electric pulse, and come in a variety of sizes and configurations.
The Electroporator market is highly competitive, with a number of companies offering a range of products. These companies include Bio-Rad Laboratories, Biosan, Corning, Eppendorf, Lonza, and Thermo Fisher Scientific. Show Less Read more